Status
Conditions
Treatments
About
Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis
Full description
In Expanded Access, treating physicians are the Sponsor.
Expanded Access requests from treating physicians may be submitted at www.pfizercares.com ; availability will depend on location/country.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Must have severe uncontrolled atopic dermatitis refractory to other available treatments
Loading...
Central trial contact
Pfizer Cares
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal